What Happened?
Emeryville, California-based Zogenix Appointed Ayush Jain as Head of Business Operations Technology
About the Company
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
About the Person
Ayush Jain is Head of Business Operations Technology at Zogenix. Previously, Ayush held various senior IT leadership roles in the industry.
Info Source
News
Short Profile